Home » Markets »Equity » Company Fundamentals

Get Company Info

Example: "532915" or "RELIGAREEQ" or “Religare”

Sun Pharmaceutical Industries Ltd.

(BSE: 524715 | NSE: SUNPHARMAEQ | ISIN: INE044A01036)

Market Cap ( Rs. Cr.) : 100052.8

974.00

7.85 (0.81%)

Open : 965.00

Volume : 68.09

High : 980.00

Low : 963.00

52Wk High : 997.95

52Wk Low : 554.00

company news »

20/05/2013
Sun Pharma. - Board Meeting on May 28, 2013

Sun Pharmaceutical Industries Ltd has informed BSE that the Honble High Court of Gujarat at Ahmedabad and
Honble High Court of Mumbai, at their res...

20/05/2013
Sun Pharma. - Board Meeting on May 28, 2013

Sun Pharmaceutical Industries Ltd has informed BSE that the Honble High Court of Gujarat at Ahmedabad and
Honble High Court of Mumbai, at their res...

17/05/2013
Sun Pharma. - Sun Pharma to announce Q4 and FY13 results on May 28, 2013

Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated May 17, 2013, titled "Sun Pharma to announce Q4 and FY13 results on...

17/05/2013
Sun Pharma. - Sun Pharma to announce Q4 and FY13 results on May 28, 2013

Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated May 17, 2013, titled "Sun Pharma to announce Q4 and FY13 results on...

15/04/2013
Sun Pharma receives tentative approval for two ANDAs

Sun Pharmaceutical Industries Ltd. today said that its subsidiary has received two tentative approvals from the US Food and Drug Administration (FDA) ...

latest results »
(Rs in Cr.)
 Dec '12 Sep '12 Jun '12 Mar '12 Dec '11 
           
Sales2865.492663.862683.472336.182145.13
Other Income67.84169.27-27.22211.87-86.34
Stock Adjustment10.15-104.32-85.23-107.28-138.61
Raw Material425.12487.16497.80496.04467.84
Power And Fuel0.000.000.000.000.00
Employee Expenses387.11356.78351.22347.95288.46
Excise0.000.000.000.000.00
Admin And Selling Expenses0.000.000.000.000.00
Research And Devlopment Expenses0.000.000.000.000.00
Expenses Capitalised0.000.000.000.000.00
Other Expenses768.58749.14677.50636.76563.67
Provisions Made0.000.000.000.000.00
Operating Profit1342.371344.371214.961174.58877.43
Interest-12.3128.2621.2111.20-59.11
Gross Profit1354.681316.111193.751163.38936.54
Depreciation84.4382.8980.1482.2677.42
Taxation236.86213.89192.49176.8363.43
Extra Ordinary Item0.00-583.580.000.000.00
Prior Year Adjustments0.000.000.000.000.00
Net Profit / Loss1033.39435.75921.12904.29795.69
Minority Interest-152.09-116.11-125.57-84.08-127.39
Share Of P/L Of Associates0.000.000.000.000.00
Net P/L After Minority Interest & Share Of Associates881.30319.64795.55820.21668.30
Cost of Investments In Subsidiary0.000.000.000.000.00
Equity Capital103.56103.56103.56103.56103.56
EPS Before Extra Ordinary Items
Basic EPS8.503.107.707.906.50
Diluted EPS8.503.107.707.906.50
EPS After Extra Ordinary Items
Basic EPS8.503.107.707.906.50
Diluted EPS8.503.107.707.906.50
Equity Dividend Rate0.000.000.000.000.00
Agg. Of Non Promoter Shares (in lacs)3761.043760.543757.543757.543757.54
Agg. Of Non Promotor Holding (%)36.3236.3136.2836.2836.28
OPM (%)45.7647.4545.7346.0942.61
GPM (%)46.1846.4544.9445.6545.48
NPM (%)35.2215.3834.6735.4838.64

about the company »

Registered & Corporate Office
Sun Pharma Advanced Research Centre (SPARC), Tandalja, Akota Road, Vadodra, Gujarat - 390020
Tel: 0265-337539, , ,
Fax: 0265-332664,
Email: secretarial@sunpharma.com
Website: www.sunpharma.com

Registrar & Share Transfer Agent

Enter BSE Code - NSE Code / Type first few Letters »

Login Get Quote

Share Market Summary Market Summary »

INDIA
NSE | -44.1| 6112.8| -0.72%
You need to upgrade your Flash Player from here
BSE | -120.66| 20103.32| -0.6%
You need to upgrade your Flash Player

FII Updates | MF Updates

US
DOW | -19.12| 15335.28| -0.12%
You need to upgrade your Flash Player
Nasdaq | -2.53 | 3496.43| -0.07%
You need to upgrade your Flash Player
Asia
Hang Seng| -126.66| 23366.37| -0.54%
You need to upgrade your Flash Player
Nikkei | 20.21| 15381.02| 0.13%
You need to upgrade your Flash Player

more

PMEAC projected 6.4% growth in India's GDP for FY 2013-14. Is it attainable?